Pill for blinding eye disease enters human testing
Disease control
Recruiting now
This study is testing a new oral tablet called HX9428 for people with wet age-related macular degeneration, a leading cause of vision loss. The first part checks the safety and correct dose of the pill. The second part will look for early signs that the pill can help improve or s…
Phase: PHASE1, PHASE2 • Sponsor: Fujian Haixi Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC